MANE expands receptor-based research with the acquisition of ChemoSensoryx
- ial
- Jan 18
- 1 min read
MANE has acquired ChemoSensoryx Biosciences, a Belgian biotech company known for its cutting-edge research into the molecular principles of chemosensory perception via olfactory, gustatory, and trigeminal receptors.
This strategic acquisition will allow MANE to gain a better scientific knowledge of how odours, tastes, and sensations like freshness or spiciness are perceived. By merging MANE's expertise with ChemoSensoryx's cutting-edge research, we want to provide more inventive and precise flavour and scent solutions, resulting in unique sensory experiences that consumers enjoy.
ChemoSensoryx provides a new technology platform for receptor-based screening and predictive modelling, which will improve MANE's capabilities in several critical areas:
Odour control and blooming technologies: Supporting innovations including FRESHPLEX™, POWERBLOOM™, and POWERLAST™.
Taste Modulation Research: Improving Our Understanding of Sweetness, Bitterness, Umami, and Kokumi.
Olfactory Receptor Modulation: guiding the design of flavours and scents that elicit certain emotional and physiological responses.
Trigeminal Receptor Modulation: Advancing study into cooling, pungent, tingling, and burning sensations.
This acquisition demonstrates MANE's dedication to providing global and growing knowledge in tastes and fragrances, resulting in long-lasting and profitable goods for customers.
Source: MANE





Comments